Effect of phenobarbitone on the low-dose dexamethasone suppression test and the urinary corticoid: Creatinine ratio in dogs

Australian Veterinary Journal

Volumn 78, Issue 1, 2000, Pages 19-23

  Foster, S F ^a   Church, D B ^a   Watson, A D J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Anticonvulsant; Dexamethasone suppression test; Dog; Human; Phenobarbitone; Urinary corticoid: creatinine ratio

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID; CREATININE; DEXAMETHASONE; DIAGNOSTIC AGENT; HYDROCORTISONE; PHENOBARBITAL;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; DRUG INTERACTION; ENDOCRINE FUNCTION TEST; FEMALE; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEIZURE; URINE;

ADRENAL CORTEX FUNCTION TESTS; ADRENAL CORTEX HORMONES; ANIMALS; ANTICONVULSANTS; CREATININE; DEXAMETHASONE; DOG DISEASES; DOGS; DRUG INTERACTIONS; FEMALE; HYDROCORTISONE; MALE; PHENOBARBITAL; PROSPECTIVE STUDIES; SEIZURES;

EID: 0033631698     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2000.tb10349.x     Document Type: Article

References (32)

1. Nugent CA, Nichols T, Tyler FH. Diagnosis of Cushing's syndrome. Arch Intern Med 1965;116:172-176.
2. Aron DC, Tyrrell JB, Fitzgerald PA et al. Cushings syndrome: problems in diagnosis. Medicine 1981;60:25-35.
3. Asfeldt VH. Simplified dexamethasone suppression test. Acta Endocrinol 1969;61:219-231.
4. Werk EE, Choi Y, Sholiton L et al. Interference in the effect of dexamethasone by diphenylhydantoin. N Engl J Med 1969;281:32-34.
5. Jubiz W, Meikle AW, Levinson RA et al. Effect of diphenylhydantoin on the metabolism of dexamethasone. N Engl J Med 1970;283:11-14.
6. Haque N, Thrasher K, Werk EE et al. Studies on dexamethasone metabolism in man: effect of diphenylhydantoin. J Clin Endocrinol 1972;34:44-50.
7. Brooks SM, Werk EE, Ackerman SJ et al. Adverse effects of phenobarbital on corticosteroid metabolism in patients with bronchial asthma. N Engl J Med 1972;286:1125-1128.
8. Meikle AW, Stanchfield JB, West CD, Tyler FH. Hydrocortisone suppression test for Cushing syndrome. Arch Intern Med 1974;134:1068-1071.
9. Kemppainen RJ, Peterson ME. Circulating concentration of dexamethasone in healthy dogs, dogs with hyperadrenocorticism, and dogs with nonadrenal illness during dexamethasone suppression testing. Am J Vet Res 1993;54:1765-1769.
10. Feldman EC, Nelson RW. Canine and feline endocrinology and reproduction. 2nd edn. Saunders, Philadelphia, 1996:187-265.
11. Chauvet AE, Feldman EC, Kass PH. Effects of phenobarbital administration on results of serum biochemical analyses and adrenocortical function tests in epileptic dogs. J Am Vet Med Assoc 1995;207:1305-1307.
12. Feldman EC, Mack RE. Urine cortisol:creatinine ratio as a screening test for hyperadrenocorticism in dogs. J Am Vet Med Assoc 1992;200:1637-1641
13. Kaplan AJ, Peterson ME, Kemppainen RJ. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs. J Am Vet Med Assoc 1995;207:445-451.
14. Woodbury DM, Pippenger CE. Other antiepileptic drugs. In: Woodbury DM, Penry JK, Pippenger CE, editors. Antiepileptic drugs. Raven Press, New York, 1982:791-801.
15. Foster SF, Church DB, Watson ADJ. Effects of phenobarbitone on serum biochemical tests in dogs. Aust Vet J 2000;78:23-26.
16. Watson ADJ, Church DB, Emslie DR, Foster SF. Plasma cortisol responses to three corticotrophic preparations in normal dogs. Aust Vet J 1998;76:255-257.
17. Toutain PL, Alvinerie M, Ruckebusch Y. Pharmacokinetics of dexamethasone and its effect on adrenal gland function in the dog. Am J Vet Res 1983;44:212-217.
18. Rijnberk A, van Wees A, Mol JA. Assessment of two tests for the diagnosis of canine hyperadrenocorticism. Vet Rec 1988;122:178-180.
19. Kemppainen RJ, Sartin JL. Effects of single intravenous doses of dexamethasone on baseline plasma cortisol concentrations and responses to synthetic ACTH in healthy dogs. Am J Vet Res 1984;45:742-746.
20. APA Task Force on Laboratory Tests in Psychiatry. The dexamethasone suppression test: an overview of its current status in psychiatry. Am J Psychiatry 1987;144:1253-1262.
21. Guthrie SK, Heidt M, Pande A et al. A longitudinal evaluation of dexamethasone pharmacokinetics in depressed patients and normal controls. J Clin Psychopharmacol 1992;12:191-196.
22. Greco DS, Brown SA, Gauze JJ et al. Dexamethasone pharmacokinetics in clinically normal dogs during low- and high-dose dexamethasone suppression testing. Am J Vet Res 1993; 54:580-585.
23. Takahashi Y, Ebihara S, Nakamura Y, Takahashi K. A model of human sleep-related growth hormone secretion in dogs: effects of 3,6, and 12 hours of forced wakefulness on plasma growth hormone, cortisol and sleep stages. Endocrinology 1981;109:262-272
24. Kemppainen RJ, Sartin JL. Evidence for episodic but not circadian activity in plasma concentrations of adrenocorticotrophin, cortisol and thyroxine in dogs. J Endcrinol 1984;103:219-226.
25. Duggan DE, Yen KC, Matalia N et al. Bioavailability of oral dexamethasone. Clin Pharmacol Therap 1975;18:205-209.
26. Brophy TRO'R, McCafferty J, Tyrer JH, Eadie MJ. Bioavailability of oral dexamethasone during high dose steroid therapy in neurological patients. Eur J Clin Pharmacol 1983;24:103-108.
27. Lowy MT, Meltzer HY. Dexamethasone bioavailability: implications for DST research. Biol Psychiatry 1987;22:373-385.
28. Farnbach GC. Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy. J Am Vet Med Assoc 1984;184:1117-1120.
29. Morton DJ, Honhold N. Effectiveness of a therapeutic drug monitoring service as an aid to the control of canine seizures. Vet Rec 1988;122:346-349.
30. Frey H-H, Kampmann E, Nielsen CK. Study on combined treatment with phenobarbital and diphenylhydantoin. Acta Pharmacol Toxicol 1968;26:284-292.
31. Ravis WR, Pedersoli WM, Wike JS. Pharmacokinetics of phenobarbital in dogs given multiple doses. Am J Vet Res 1989;50:1343-1347.
32. Thurman GD, McFadyen ML, Miller R. The Pharmacokinetics of phenobarbitone in fasting and non-fasting dogs. J S Afr Vet Assoc 1990;61:86-89